W G Nichols
Overview
Explore the profile of W G Nichols including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yeni P, Lamarca A, Berger D, Cimoch P, Lazzarin A, Salvato P, et al.
HIV Med
. 2009 Feb;
10(2):116-24.
PMID: 19200175
Background: This phase IIb study explored the antiviral activity and safety of the investigational CC chemokine receptor 5 (CCR5) antagonist aplaviroc (APL) in antiretroviral-naïve patients harbouring R5- or R5X4-tropic virus....
2.
Nichols W, Steel H, Bonny T, Adkison K, Curtis L, Millard J, et al.
Antimicrob Agents Chemother
. 2007 Dec;
52(3):858-65.
PMID: 18070967
Aplaviroc (APL) was a new CCR5 antagonist that was investigated in two dose-ranging studies with antiretroviral therapy-naïve, human immunodeficiency virus-infected adults: ASCENT, in which 147 subjects were randomized 2:2:1 to...
3.
Chien J, Martin P, Flowers M, Nichols W, Clark J
Bone Marrow Transplant
. 2004 Feb;
33(7):759-64.
PMID: 14968136
The clinical significance of early airflow decline after myeloablative allogeneic hematopoietic SCT is uncertain. We performed a retrospective cohort analysis to determine if airflow decline by day 100 is associated...
4.
Nichols W, Gooley T, Boeckh M
Biol Blood Marrow Transplant
. 2002 Jan;
7 Suppl:11S-15S.
PMID: 11777098
Community respiratory viruses (CRVs) are an important cause of morbidity and mortality among recipients of hematopoietic stem cell transplants (HSCT). At the Fred Hutchinson Cancer Research Center, respiratory syncytial virus...
5.
Nichols W, Corey L, Gooley T, Davis C, Boeckh M
Blood
. 2001 Jul;
98(3):573-8.
PMID: 11468152
Parainfluenza virus (PIV) infections may be significant causes of morbidity and mortality in patients undergoing stem cell transplantation, but data regarding their impact on transplant-related mortality is limited. This study...
6.
Nichols W, Corey L, Gooley T, Drew W, Miner R, Huang M, et al.
Blood
. 2001 Feb;
97(4):867-74.
PMID: 11159510
To determine the risk factors and outcomes associated with rising cytomegalovirus (CMV) antigenemia levels during preemptive therapy among stem cell allograft recipients, 119 patients with CMV antigenemia were studied. Patients...
7.
Nichols W, Boeckh M
J Clin Virol
. 2000 Feb;
16(1):25-40.
PMID: 10680738
The introduction of highly active antiretroviral therapy (HAART) for HIV has had a major impact on the treatment of CMV disease in HIV-infected individuals. There is mounting evidence that in...
8.
Staats H, Nichols W, Palker T
J Immunol
. 1996 Jul;
157(1):462-72.
PMID: 8683152
To optimize mucosal immune responses to the HIV-1 peptide vaccine candidate T1SP10 MN(A), we intranasally immunized BALB/c and C57BL/6 mice with C4/V3 HIV-1 peptide together with the mucosal adjuvant cholera...
9.
KIRBY C, Nichols W, GARRITANO A, WOHL G, PIETROLUONGO A
Surgery
. 1955 Feb;
37(2):267-71.
PMID: 13226166
No abstract available.